Thymosin Alpha-1 10 mg

Lot VBL-TA10-1

✓ Independently verified by ILS Laboratories

This batch was independently verified by an ISO/IEC 17025-accredited laboratory for identity, purity, and safety.

Identity

✓ Confirmed

Purity

98.46%

Endotoxin

PASS

NMT 0.05 EU/mL

Fentanyl

Not Detected

Independent laboratory verification. Supplements — does not replace — the Velora portal and laboratory report.

Laboratory Information

Testing Laboratory: ILS Laboratories (ISO/IEC 17025 accredited)
Source COA Number: COA-2026-01F-JN
Analysis Date: 2026-08-19
Analytical Methods: Purity, Identity & Quantitation (HPLC), Endotoxin (USP <85>)

Independent Verification

This report can be confirmed directly with the testing laboratory.

Technical Data

Net Peptide Content: 10.33 mg
Appearance: Good
Methodology: Peptide purity determined by RP-HPLC area normalization at 214 nm. Value represents the percentage of the target peptide relative to all peptide-related peaks. Non-peptide process-related impurities, if detected, are excluded from the calculation.
Technical Notes: Sample confirmed to be Thymosin Alpha-1 by HPLC (identification by chromatographic retention-time comparison with a reference standard). Endotoxin tested per USP <85> kinetic chromogenic method; reported result NMT 0.05 EU/mL. Fentanyl screen: immunoassay, 50 ng/mL cutoff, Not Detected. Customer COA document: https://f004.backblazeb2.com/file/ils-lab-assets/coa-pdfs/velora-biolabs-VBL-TA10-1-KPRzuv.pdf

Research Use Only (RUO). Verification reflects the analyzed batch identified above.